Thornton Law Firm
  • Home
  • About
  • Cases We Handle
    • Birth Defects
    • Drugs and Medical Devices Litigation
    • False Claims Act and Fraud
    • Mesothelioma and Asbestos
    • Personal Injury
    • PFAS Chemical Exposure
    • Silicosis
    • Toxic Torts
  • Attorneys
    • Our Partner Attorneys
      • Michael P. Thornton
      • David J. McMorris
      • David C. Strouss
      • Andrew S. Wainwright
      • Michael A. Lesser
      • Marilyn T. McGoldrick
      • Brad J. Mitchell
      • Andrea Marino Landry
      • Evan R. Hoffman
      • Leah McMorris
      • Brian J. Freer
      • Leslie-Anne Taylor
      • Christian F. Uehlein
    • Our Associate Attorneys
      • Ginger A. Gibbs
      • Malissa A. Riehl
      • Dhespina Poreci
      • Justin Carter
    • Of Counsel Attorneys
      • John T. Barrett
      • David Bricker
      • Patricia M. Flannery
    • Asbestos Staff
      • Allison Elder
      • Lisa Peterson
      • Joseph D. Souza
      • Chris Corradetti
      • David A. Talanian
  • Significant Cases
  • Blog
  • Careers
  • Contact
  • Call: (888) 491-9726
Select Page
$2.3 Million Verdict Against Takeda for Actos User with Bladder Cancer

$2.3 Million Verdict Against Takeda for Actos User with Bladder Cancer

by Marilyn T. McGoldrick | Feb 13, 2015 | Uncategorized

Posted by Marilyn McGoldrick on Feb 13, 2015 2:08:55 PM A Philadelphia state court jury awarded a $2.3 million dollar verdict against Takeda Pharmaceuticals, Inc., to John Kristufek, a retired teacher who developed bladder cancer after taking the diabetes...
$2.3 Million Verdict Against Takeda for Actos User with Bladder Cancer

Xarelto Litigation Update: 5 Key Points

by Marilyn T. McGoldrick | Jan 22, 2015 | Uncategorized

Thornton Law Firm is no longer accepting new Xarelto cases. By Marilyn McGoldrick Posted on Jan 22, 2015 The blood thinner Xarelto can lead to life-threatening uncontrollable internal bleeding. Currently, there is no reversal agent (antidote) to stop bleeding caused...
$2.3 Million Verdict Against Takeda for Actos User with Bladder Cancer

February Bellwether Trials Of C. R. Bard Mesh Cases Won’t Be Delayed

by Marilyn T. McGoldrick | Jan 14, 2015 | Uncategorized

Posted by Marilyn T. McGoldrick on Jan 14, 2015 12:29:03 PM The federal judge overseeing all transvaginal mesh litigation has denied C.R. Bard’s motion to delay bellwether trials, also known as test trials, scheduled for next month. C.R. Bard, a defendant in...
$2.3 Million Verdict Against Takeda for Actos User with Bladder Cancer

Xarelto Uncontrollable Bleeding Lawsuits Consolidated In Louisiana

by Marilyn T. McGoldrick | Dec 30, 2014 | Uncategorized

Thornton Law Firm is no longer accepting new Xarelto cases. By Marilyn McGoldrick Posted on Dec 30, 2014 Patients taking the blood thinning medication Xarelto to prevent blood clots and strokes in patients with irregular heart rhythms have continued to...
$2.3 Million Verdict Against Takeda for Actos User with Bladder Cancer

Power Morcellators Get Toughest FDA Black Box Warning For Cancer Risk

by Marilyn T. McGoldrick | Dec 3, 2014 | Uncategorized

Posted by Marilyn McGoldrick on Dec 3, 2014 12:29:42 PM The FDA has issued a warning that power morcellators can spread cancer, and now recommends against the tool’s use in most hysterectomies (removal of the uterus)...
« Older Entries
Next Entries »
Copyright © 2024 Thornton Law Firm. All rights reserved.

Tenlaw uses cookies to provide security and better understand how our website is used. By using this website, you agree with the use of cookies. For more information see our Cookie Notice. By clicking Accept, you agree to our privacy policy and use of these cookies.

Read Our Privacy Policy

Thornton Law Firm
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.